TABLE 1.
Age, clinical parameters, geographical locations, RNASEL genotypes, and presence of XMRV sequences for prostate cancer patientsa
| Patient (VP no.) | Age (yr) | Clinical stage | PSA (ng/ml) | Tumor grade | Pathological stage | Region | RNASEL | XMRV |
|---|---|---|---|---|---|---|---|---|
| 626 | 67 | T2a | 4.4 | 9 (5 + 4) | Extraprostatic extension | Northeastern OH | RQ (GA) | Negative |
| 627 | 49 | T1c | 4.1 | 6 (3 + 3) | Organ confined | Northeastern OH | RR (GG) | Negative |
| 629 | 64 | T1c | 4.1 | 7 (3 + 4) | Organ confined | Northeastern OH | RQ (GA) | Negative |
| 630 | 68 | T1c | 8.6 | 7 (3 + 4) | Organ confined | Northeastern OH | RR (GG) | Negative |
| 633 | 74 | T1c | 4.3 | 8 (4 + 4) | Extraprostatic extension | Southern FL | RQ (GA) | Negative |
| 635 | 72 | T1c | 18 | 9 (4 + 5) | Extraprostatic extension | Southern FL | RR (GG) | Positive |
| 636 | 57 | T1c | 4.4 | 7 (3 + 4) | Extraprostatic extension | Northeastern OH | RQ (GA) | Negative |
| 638 | 60 | T1c | 5.8 | 6 (3 + 3) | Organ confined | Southwestern OH | RR (GG) | Negative |
| 641 | 60 | T1c | 4.5 | 6 (3 + 3) | Extraprostatic extension | Northeastern OH | RQ (GA) | Negative |
| 647 | 60 | T1c | 2.8 | 7 (4 + 3) | Organ confined | Northeastern OH | QQ (AA) | Negative |
| 653 | 63 | T1c | 6.8 | 8 (4 + 4) | Extraprostatic extension | Northeastern OH | RR (GG) | Negative |
| 657 | 58 | T1c | 4.6 | 7 (3 + 4) | Organ confined | Northeastern OH | RR (GG) | Positive |
| 658 | 58 | NA | 0.4 | 6 (3 + 3) | Organ confined | Northeastern OH | RR (GG) | Negative |
| 663 | 65 | T1c | 6.8 | 8 (4 + 4) | Organ confined | Northeastern OH | QQ (AA) | Negative |
| 667 | 69 | T1c | 1.9 | 7 (3 + 4) | Extraprostatic extension | Southwestern OH | QQ (AA) | Positive |
| 672 | 50 | T1c | 10.6 | 7 (3 + 4) | Extraprostatic extension | Northeastern OH | RR (GG) | Negative |
| 673 | 70 | T1c | 11 | 8 (4 + 4) | Extraprostatic extension | SC | RQ (GA) | Negative |
| 674 | 52 | T1c | 4.6 | 6 (3 + 3) | Organ confined | Northeastern OH | RQ (GA) | Negative |
| 677 | 71 | T1c | 7.2 | 8 (4 + 4) | Extraprostatic extension | Southwestern OH | RR (GG) | Negative |
| 683 | 48 | T1c | 5.3 | 7 (3 + 4) | Organ confined | Northeastern OH | QQ (AA) | Negative |
| 693 | 56 | T1c | 4.2 | 6 (3 + 3) | Organ confined | Southwestern OH | RR (GG) | Positive |
| 695 | 65 | T1c | 8.7 | 7 (3 + 4) | Organ confined | Northeastern OH | RR (GG) | Negative |
| 700 | 70 | T1c | 6.5 | 7 (3 + 4) | Extraprostatic extension | Southwestern OH | RR (GG) | Negative |
| 702 | 49 | T2a | 11.5 | 9 (4 + 5) | Extraprostatic extension | Northeastern OH | RR (GG) | Negative |
| 723 | 60 | T1c | 44.3 | 9 (5 + 4) | Extraprostatic extension & nodal metastasis | SC | RQ (GA) | Negative |
| 728 | 62 | T1c | 5.6 | 6 (3 + 3) | Organ confined | Northeastern OH | RR (GG) | Negative |
| 730 | 70 | T1c | 14.3 | 8 (4 + 4) | Extraprostatic extension | Northeastern OH | RQ (GA) | Negative |
| 731 | 60 | T1c | 12.3 | 7 (4 + 3) | Organ confined | Northeastern OH | RQ (GA) | Negative |
| 739 | 65 | T1c | 5.1 | 7 (3 + 4) | Organ confined | Northeastern OH | RQ (GA) | Negative |
| 740 | 59 | T2a | 11.8 | 7 (4 + 3) | Organ confined | Northeastern OH | RQ (GA) | Negative |
| 742 | 63 | T2a | 7.1 | 6 (3 + 3) | Organ confined | Western PA | QQ (AA) | Negative |
| 744 | 61 | T1c | 4.4 | 7 (3 + 4) | Organ confined | Northeastern OH | RR (GG) | Negative |
a
Data for XMRV-positive patients are in boldface.